12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Name: 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
Published: 2015
License: Public Domain

University Health Network, Toronto · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

bipolar bipolardisorder inflammation

bipolar depression, bipolar disorder, inflammation, bipolar, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Related documents